Avanos Medical, Inc.
AVNS
$24.96
$0.000.00%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 492.31% | 7.14% | 98.18% | -1,263.64% | 101.66% |
| Total Depreciation and Amortization | 3.03% | 5.32% | -6.00% | 4.17% | -13.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 197.96% | -155.06% | -88.93% | 1,860.98% | -98.97% |
| Change in Net Operating Assets | -232.24% | 944.83% | 57.35% | -225.93% | -88.00% |
| Cash from Operations | -143.62% | 101.43% | 105.88% | -73.54% | -55.61% |
| Capital Expenditure | 37.68% | 1.43% | 36.36% | -64.18% | -39.58% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | 101.06% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,600.00% | 0.00% | 90.91% | 8.33% | -242.86% |
| Cash from Investing | -13.24% | 78.41% | -138.64% | -45.05% | -19.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 4.17% | -4.35% | 4.17% | 91.21% | 0.00% |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | -- |
| Repurchase of Common Stock | -333.33% | -- | 100.00% | 63.64% | -2,100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -18.52% | -35.00% | 37.50% | 89.00% | -6.20% |
| Foreign Exchange rate Adjustments | -266.67% | 300.00% | -110.34% | 61.11% | 142.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -225.39% | 197.47% | -195.52% | 37.38% | -157.22% |